Medicine matched with radioactive therapy for nasopharyngeal carcinoma

The invention discloses a medicine matched with radioactive therapy for nasopharyngeal carcinoma. The medicine is prepared from an internally taking drug and externally applying powder, wherein the internally taking drug is prepared from the following medicinal raw materials: ginseng, astragalus membranaceus, donkey-hide gelatin, Chinese yam, radix paeoniae alba, radix bupleuri, morinda officinalis, fructus lycii, semen ziziphi spinosae, radix scrophulariae, dendrobe, radix rehmanniae recen, radix polygonati officinalis, rhizoma anemarrhenae, rheum officinale, houttuynia cordata, dandelion, edible tulip, hawthorn, poria cocos, rhizoma atractylodis macrocephalae, rhizoma corydalis, radix paeoniae rubra, moutan bark, radix achyranthis bidentatae, spatholobus suberctu, fritillary bulb and licorice root; and the externally applying powder is prepared from the following medicinal raw materials: cape jasmine, gallnut, safflower carthamus, dragon blood and borneol. The medicine prepared by the formula of the traditional Chinese medicinal herbs can be used for treating side effects caused by radioactive therapy for nasopharyngeal carcinoma and reinforcing the constitution and resistance of patients to help patients early back to health, and has a clinical effective rate of 100 percent.